ArticlePharmaceutics2026

A Hierarchical Microglial-Targeting Nanoplatform for the Therapy of Parkinson's Disease by Modulating Mitochondrial Dysfunction.

Yue Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.